Screener
Kyntra Bio KYNB Q4 2025 Annual earnings
Reported March 16, 2026 · After market close
Revenue$1.3MMiss by $370.0K
EPS-$3.61Beat by $0.28
Revenue estimate$1.7M
EPS estimate-$3.89
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$1.8M
EPS estimate-$3.66
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Kyntra Bio report Q4 2025 earnings?
- Kyntra Bio (KYNB) reported Q4 2025 earnings on March 16, 2026 after market close.
- What were Kyntra Bio's Q4 2025 revenue and EPS?
- Kyntra Bio reported revenue of $1.3M and eps of $-3.61 for Q4 2025.
- Did Kyntra Bio beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $1.7M by $370.0K. EPS beat the consensus estimate of $-3.89 by $0.28.
- How did Kyntra Bio's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 101.1% from -$123.3M a year earlier and eps declined 4412.5% from $-0.08.
- Where can I find Kyntra Bio's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-108324) and the 10-K periodic report (0001193125-26-108346) directly on SEC EDGAR. The filing index links above go to sec.gov.
